Table 3 Stages and Prior Systemic Therapies of DAB/IL2 Responders
Stage | Age | Prior Systemic Therapy | # Cycles | Response |
|---|---|---|---|---|
M1A (7/10) | 59 | None | 4 | PR |
78 | None | 2 | SD | |
83 | None | 2 | MR | |
64 | ADI, BCT, αCTLA4, VAC | 4 | PR | |
60 | AIFN, BCT, TEM | 4 | PR | |
45 | ADI, IFN, VAC | 4 | PR | |
75 | AIFN, BCT | 4 | SD | |
M1B (1/8) | 67 | ADI | 4 | SD |
M1C (14/42) | 78 | None | 2 | PR |
83 | None | 3 | PR | |
82 | None | 3 | PR | |
61 | None | 4 | PR | |
59 | None | 4 | MR | |
47 | BCT, HDIL2, TKI258 | 3 | PR | |
62 | αCTLA4 | 4 | PR | |
55 | BCT, HDIL2, TKI258 | 4 | MR | |
70 | ADI, BCT | 2 | MR | |
30 | BCT | 4 | MR | |
30 | BCT, HDIL2, αCTLA4, TKI258 | 2 | MR | |
45 | BCT | 4 | MR | |
61 | BCT | 3 | MR | |
58 | ADI, VAC | 4 | MR |